Genmab A/S Sponsored ADR GMAB

35.32 0.49 1.41% as of 25 Sep
Market cap
$20.8B
P/E
27.8×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

3,585.00 3,720.00 3,901.00 4,131.00
Cost of Revenue
205.00 238.00 261.00 288.00
Gross Profit
3,380.00 3,482.00 3,640.00 3,843.00
R&D Expenses
1,462.00 1,606.00 1,687.00 1,782.00
SG&A Expenses
586.00 626.00 666.00 727.00
Operating Income
1,317.00 1,065.00 1,057.00 1,072.00
Non-operating Income/Expense
349.00 139.00 (23.00) (166.00)
Non-operating Interest Expenses
282.00 269.00 374.00 422.00
EBT
1,666.00 1,204.00 1,034.00 906.00
Income Tax Provision
182.00 241.00 213.00 118.00
Income after Tax
1,484.00 963.00 821.00 788.00
Net Income Common
1,484.00 963.00 821.00 788.00
EPS (Basic)
2.36 1.55 1.32 1.27
Gross Margin
94.28% 93.60% 93.31% 93.03%
EBIT Margin
36.74% 28.63% 27.10% 25.95%
EBT margin
46.47% 32.37% 26.51% 21.93%
Net Profit Margin
41.39% 25.89% 21.05% 19.08%
Free Cash Flow Margin
33.16% (163.55%) (161.65%) (153.64%)
EBITDA
1,384.00 1,136.00 1,141.00 1,166.00
EBIT
1,317.00 1,065.00 1,057.00 1,072.00
EPS (Diluted, from Cont. Ops)
2.35 1.54 1.31 1.26
EPS (Basic, Consolidated)
2.36 1.55 1.33 1.28
EPS (Basic, from Continuous Ops)
2.36 1.55 1.33 1.28
Income from Continuous Operations
1,484.00 963.00 821.00 788.00
Consolidated Net Income/Loss
1,484.00 963.00 821.00 788.00
EBITDA Margin
38.61% 30.54% 29.25% 28.23%
Operating Cash Flow Margin
35.54% 31.88% 23.12% 21.57%

Fold the line items

In millions of $ except per-share values · columns are period end dates